Two leading North West businessmen have launched an ambitious new campaign to raise £1million for The Christie charity by April 2014. The funds will be used to introduce a new mobile chemotherapy unit for the North West region, enabling patients to receive treatment closer to home.
Led by Rob Cotton, CEO of global information assurance firm NCC Group, and Mike Perls, CEO of communications agency MC2, the 'On The Road to Recovery campaign' has a series of fundraising activities planned including a star-studded comedy event in October and a ruthless cycling challenge in September.
The 'On the Road to Alp D'Huez' challenge will see a team of 18 local business leaders tackle 5 iconic stages of the Tour De France back to back, covering 650km over the course of five days.
Staff members from NCC Group have already donated over £87,000 to the cause, with more businesses expected to come on board with the challenge over the next few months.
Rob Cotton said: "This is a really exciting project to be involved with and a cause that is extremely close to my heart.
"The Christie provides valuable support to cancer patients in the North West and mobile chemotherapy units will help it to deliver care much closer to the patient's home.
"The Tour De France Challenge will be an incredibly difficult feat of physical and mental strength but a great experience and we are looking forward to challenging both our businesses and our bodies in order to raise money for such a worthy cause."
Dr Andrew Wardley, clinical lead for chemotherapy at The Christie, said; "This is an incredible challenge so huge thanks to Rob and Mike for leading the way.
"The mobile chemotherapy unit will be a great benefit to patients allowing them to have The Christie experience of specialised care and the best outcomes delivered close to where they live. It will make an enormous difference.
"The best of luck to everyone joining this campaign - all money raised will help cancer patients throughout Greater Manchester."
The Christie is one of Europe's leading cancer treatments centres, based in South Manchester with radiotherapy centres in Salford and Oldham.